TERC and teratoma: In the present work, we employed the in vitro embryoid body (EB), in vivo teratoma, as well as an in vitro directed differentiation assay to evaluate the differentiation capacities of Terc−/−, Terc+/−, and wild-type (Terc+/+) ntESCs.